As we sit and speculate 26 hours a day (speaking for myself), Nader and team are confidently calm. NP's statement via email last night spoke volumes to me. "the MOA of Leronlimab the world needs. If other drugs can help then God bless them."
Dr. Lelezari and Dr. Patterson have also been extraordinarily confident.
Many of us are wondering if they know something, or if they are just getting ahead of themselves. The issue is that most of us are looking at Leronlimab through the prism of traditional medicine. (ie you take a chemical and it has a reaction in the body that helps, but also causes some other issues. This chemical reaction varies from person to person and thus the only way to determine efficacy is to test it on many people)
AFTER YOU READ THIS NEXT PART THINK BACK, OR GO RE-WATCH THE ARTICLES AND VIDEOS DESCRIBING THE MOA IN CANCER AND COVID:
Leronlimab is different. It flips a switch on the CCR5 receptor. This is not something that varies from person to person. It TURNS OFF the signaling of the CCL5 to the CCR5 receptor. This is why (albeit early) we are seeing the elimination of circulating tumor cells in the cancer patient. (not a reduction, not in some people. COMPLETE elimination)
My bold prediction, is that over time the evidence will show that Leronlimab ELIMINATES the cytokine storm. If taken at the onset, I believe it will have 100% efficacy against the virus. We will see deaths in the critical group, because they received Leronlimab too late. Some of them will die with 0 viral load. I believe that patients that receive Leronlimab early will all recover.
I recognize this is quite bold, and some will disagree. Time will tell if this is true.